Probiotic and postbiotic activity in health and disease: Comparison on a novel polarised ex-vivo organ culture model

Gut

Volumn 61, Issue 7, 2012, Pages 1007-1015

  Tsilingiri, Katerina ^a   Barbosa, Theolis ^a   Penna, Giuseppe ^a   Caprioli, Flavio ^b   Sonzogni, Angelica ^a   Viale, Giuseppe ^a   Rescigno, Maria ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 23; INTERLEUKIN 23P40; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; POSTBIOTIC AGENT; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BACTERIAL STRAIN; CELL HOMING; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; ENTERITIS; EX VIVO STUDY; HOMEOSTASIS; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INTESTINE MUCOSA; LACTOBACILLUS PARACASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; LAMINA PROPRIA; ORGAN CULTURE; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; UPREGULATION;

CYTOKINES; DIETARY SUPPLEMENTS; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; LACTOBACILLUS; ORGAN CULTURE TECHNIQUES; PROBIOTICS; SALMONELLA;

EID: 84861578826     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-300971     Document Type: Article

References (29)

1. Zhao L, Shen J. Whole-body systems approaches for gut microbiota-targeted, preventive healthcare. J Biotechnol 2010;149:183-90.
2. Fujimura KE, Slusher NA, Cabana MD, et al. Role of the gut microbiota in defining human health. Expert Rev Anti Infect Ther 2010;8:435-54.
3. Sansonetti PJ. War and peace at mucosal surfaces. Nat Rev Immunol 2004;4:953-64. (Pubitemid 39620070)
4. Rescigno M, Di Sabatino A. Dendritic cells in intestinal homeostasis and disease. J Clin Invest 2009;119:2441-50.
5. Rescigno M. The pathogenic role of intestinal flora in IBD and colon cancer. Curr Drug Targets 2008;9:395-403. (Pubitemid 352025214)
6. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009;361:2066-78.
7. Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 2008;105:16731-6.
8. Garrett WS, Gordon JI, Glimcher LH. Homeostasis and inflammation in the intestine. Cell 2010;140:859-70.
9. Vanderpool C, Yan F, Polk DB. Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases. Inflamm Bowel Dis 2008;14:1585-96.
10. Isaacs K, Herfarth H. Role of probiotic therapy in IBD. Inflamm Bowel Dis 2008;14:1597-605.
11. FAO/WHO. FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics. 2001.
12. Besselink MG, van Santvoort HC, Buskens E, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008;371:651-9.
13. Daneman R, Rescigno M. The gut immune barrier and the blood-brain barrier: are they so different? Immunity 2009;31:722-35.
14. Lee J, Gonzales-Navajas JM, Raz E. The "polarizing-tolerizing" mechanism of intestinal epithelium: its relevance to colonic homeostasis. Semin Immunopathol 2008;30:3-9. (Pubitemid 351178626)
15. Lee J, Mo JH, Katakura K, et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol 2006;8:1327-36. (Pubitemid 44835107)
16. Mastroeni P, Skepper JN, Hormaeche CE. Effect of anti-tumor necrosis factor alpha antibodies on histopathology of primary Salmonella infections. Infect Immun 1995;63:3674-82.
17. Mileti E, Matteoli G, Iliev ID, et al. Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS One 2009;4:e7056.
18. Menten P, Wuyts A, Van Damme J. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev 2002;13:455-81. (Pubitemid 35303816)
19. Macdonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science 2005;307:1920-5. (Pubitemid 40404695)
20. Dharmani P, Chadee K. Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key. Curr Mol Pharmacol 2008;1:195-212.
21. Boirivant M, Strober W. The mechanism of action of probiotics. Curr Opin Gastroenterol 2007;23:679-92. (Pubitemid 47508800)
22. Coombes JL, Powrie F. Dendritic cells in intestinal immune regulation. Nat Rev Immunol 2008;8:435-46. (Pubitemid 351733420)
23. Rimoldi M, Chieppa M, Salucci V, et al. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol 2005;6:507-14. (Pubitemid 41716764)
24. Iliev ID, Mileti E, Matteoli G, et al. Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning. Mucosal Immunol 2009;2:340-50.
25. Iliev ID, Spadoni I, Mileti E, et al. Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells. Gut 2009;58:1481-9.
26. Kamada N, Hisamatsu T, Okamoto S, et al. Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis. J Clin Invest 2008;118:2269-80. (Pubitemid 351872344)
27. Marteyn B, West NP, Browning DF, et al. Modulation of Shigella virulence in response to available oxygen in vivo. Nature 2010;465:355-8.
28. Salim SY, Soderholm JD. Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm Bowel Dis 2011;17:362-81.
29. Vetrano S, Rescigno M, Cera MR, et al. Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease. Gastroenterology 2008;135:173-84. (Pubitemid 351899025)